A. L. Adams

Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed

P. Engstrom, S. Litwin, L. Weiner, 2002, Cancer Chemotherapy and Pharmacology.

Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model

J. Gallo, P. Guo, Jianguo Ma, 2001, Cancer Chemotherapy and Pharmacology.

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.

S. Litwin, L. Weiner, C. Langer, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.

M. Millenson, R. Ozols, L. Weiner, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I T rial o f M ultiple C ycles o f H igh-Dose C arboplatin, Paclitaxel, a nd T opotecan W ith P eripheral-Blood S tem- Cell S upport a s F ront-Line T herapy

M. Millenson, R. Ozols, L. Weiner, 2001 .

Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).

R. Winneker, E. Melenski, Jeff Cohen, 2008, Journal of medicinal chemistry.